Active Clinical Trial Studies
Find a Clinical Trial
Below is a list of currently active Phase I, II, III and IV trials. You can also search for a specific clinical trial using the field provided.
Clinical Trials match your criteria
-
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of IBS-C in Pediatric Patients 12 to 18 Years Old
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Pediatric Patients 12 to Less than 18 Years Old
-
Incidence of Surgical Site Complications Following Cesarean Delivery Closure Comparing Absorbable Subcuticular Staples with Conventional Closure
Incidence of Surgical Site Complications Following Cesarean Delivery Closure Comparing Absorbable Subcuticular Staples with Conventional Closure
-
Intraoperative Radiation Exposure in Idiopathic Scoliosis Surgery with Freehand Technique of Pedicle Screws: A Comparison with Navigation Techniques
Intraoperative Radiation Exposure in Idiopathic Scoliosis Surgery with Freehand Technique of Pedicle Screws: A Comparison with Navigation Techniques
-
A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children with Growth Hormone Deficiency
A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children with Growth Hormone Deficiency (GHD)
-
Vivistim Registry for Paired VNS Therapy (GRASP)
Vivistim Registry for Paired VNS Therapy (GRASP)/(Bayfront)
-
A 2-Part, Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children under 12 Years of Age with Hyperkalaemia (EMERALD2)
A 2-Part, Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children under 12 Years of Age with Hyperkalaemia (EMERALD2)
-
A Phase 2 Study of Blinatumomab in Combination With Chemotherapy for Infants With Newly Diagnosed Acute Lymphoblastic Leukemia With Randomization of KMT2A-Rearranged Patients to Addition of Venetoclax
A Phase 2 Study of Blinatumomab in Combination with Chemotherapy for Infants with Newly Diagnosed Acute Lymphoblastic Leukemia with Randomization of KMT2A-Rearranged Patients to Addition of Venetoclax
-
A Study Testing the Combo of Dasatinib or Imatinib to Chemo Treatment W/ Blinatumomab for Children, Adolescents, & YA W/ Ph+ or Ph-Like B-cell B-ALL
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
-
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
S25.184.07
-
Radiation Exposure in Prosthetic Total Hip Arthroplasty Dislocations
Radiation Exposure in Prosthetic Total Hip Arthroplasty Dislocations
